Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemia by Ross L. Levine, Peter J.M. Valk

Get full text

Exon 8 splice site mutations in the gene encoding the E3-ligase CBL are associated with core binding factor acute myeloid leukemias by Saman Abbas, Gabriëlle Rotmans, Bob Löwenberg, Peter J.M. Valk

Get full text

Prevalence of a new auto-activating colony stimulating factor 3 receptor mutation (CSF3R-T595I) in acute myeloid leukemia and severe congenital neutropenia by Renée Beekman, Marijke Valkhof, Paulette van Strien, Peter J.M. Valk, Ivo P. Touw

Get full text

Sex disparity in acute myeloid leukaemia with FLT3 internal tandem duplication mutations: implications for prognosis by Monica Hellesøy, Caroline Engen, Tim Grob, Bob Löwenberg, Peter J. M. Valk, Bjørn T. Gjertsen

Get full text

Trisomy 13 correlates with RUNX1 mutation and increased FLT3 expression in AML-M0 patients by Fernando P.G. Silva, Alexandra Lind, Geeske Brouwer-Mandema, Peter J.M. Valk, Micheline Giphart-Gassler

Get full text

Digital PCR for BCR-ABL1 Quantification in CML: Current Applications in Clinical Practice by Camille C.B. Kockerols, Peter J.M. Valk, Mark-David Levin, Niels Pallisgaard, Jan J. Cornelissen, Peter E. Westerweel

Get full text

The antioxidant protein peroxiredoxin 4 is epigenetically down regulated in acute promyelocytic leukemia. by Karishma K Palande, Renee Beekman, Lotte E van der Meeren, H Berna Beverloo, Peter J M Valk, Ivo P Touw

Get full text

Long‐term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome by Anna M. Aalbers, Paul L. A. vanDaele, Virgil A. S. H. Dalm, Peter J. M. Valk, Marc H. G. P. Raaijmakers

Get full text

Azacytidine Treatment for VEXAS Syndrome by Marc H. G. P. Raaijmakers, Maud Hermans, Anna Aalbers, Melissa Rijken, Virgil A. S. H. Dalm, Paul van Daele, Peter J. M. Valk

Get full text

Retroviral integration mutagenesis in mice and comparative analysis in human AML identify reduced PTP4A3 expression as a prognostic indicator. by Renée Beekman, Marijke Valkhof, Stefan J Erkeland, Erdogan Taskesen, Veronika Rockova, Justine K Peeters, Peter J M Valk, Bob Löwenberg, Ivo P Touw

Get full text

The Landscape of KMT2A-PTD AML: Concurrent Mutations, Gene Expression Signatures, and Clinical Outcome by Adil S.A. Al Hinai, Marta Pratcorona, Tim Grob, François G. Kavelaars, Elena Bussaglia, Mathijs A. Sanders, Josep Nomdedeu, Peter J.M. Valk

Get full text

FLT3‐ITD mutations in acute myeloid leukaemia – molecular characteristics, distribution and numerical variation by Caroline Engen, Monica Hellesøy, Tim Grob, Adil Al Hinai, Atle Brendehaug, Line Wergeland, Siv Lise Bedringaas, Randi Hovland, Peter J. M. Valk, Bjørn T. Gjertsen

Get full text

Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD by Hendrik J.M. de Jonge, Peter J.M. Valk, Eveline S.J.M. de Bont, Jan Jacob Schuringa, Gert Ossenkoppele, Edo Vellenga, Gerwin Huls

Get full text

Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001 by Luca L.G. Janssen, Theresia M. Westers, Jeroen Rovers, Peter J.M. Valk, Jacqueline Cloos, Tanja D. de Gruijl, Arjan A. van de Loosdrecht

Get full text

RNA sequencing reveals a unique fusion of the lysine (K)-specific methyltransferase 2A and smooth muscle myosin heavy chain 11 in myelodysplastic syndrome and acute myeloid leukemi... by Mathijs A. Sanders, François G. Kavelaars, Annelieke Zeilemaker, Adil S.A. Al Hinai, Saman Abbas, H. Berna Beverloo, Kirsten van Lom, Peter J.M. Valk

Get full text

Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling by Roel G.W. Verhaak, Bas J. Wouters, Claudia A.J. Erpelinck, Saman Abbas, H. Berna Beverloo, Sanne Lugthart, Bob Löwenberg, Ruud Delwel, Peter J.M. Valk

Get full text

Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value by Marta Pratcorona, Saman Abbas, Mathijs A. Sanders, Jasper E. Koenders, François G. Kavelaars, Claudia A.J. Erpelinck-Verschueren, Annelieke Zeilemakers, Bob Löwenberg, Peter J.M. Valk

Get full text

Prognostic relevance of molecular measurable residual disease detection in AML with mutated CEBPA by Christian M. Vonk, Emma L. Boertjes, Francois G. Kavelaars, Melissa Rijken, Jolinda M. L. Konijnenburg, Roxanne E. Cromwell, Bob Löwenberg, Tim Grob, Peter J. M. Valk

Get full text

Next-Generation Sequencing Analysis of the Human TCRγδ+ T-Cell Repertoire Reveals Shifts in Vγ- and Vδ-Usage in Memory Populations upon Aging by Martine J. Kallemeijn, François G. Kavelaars, Michèle Y. van der Klift, Ingrid L. M. Wolvers-Tettero, Peter J. M. Valk, Jacques J. M. van Dongen, Anton W. Langerak

Get full text

Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates by Judith M. Boer, Jasper E. Koenders, Bronno van der Holt, Carla Exalto, Mathijs A. Sanders, Jan J. Cornelissen, Peter J.M. Valk, Monique L. den Boer, Anita W. Rijneveld

Get full text